Portable corneal imaging as a dry-eye trial endpoint
Pleryon's dry-eye trial needs objective ocular-surface measures; Ocuwell's portable corneal topography device is already used by clinicians. Using OCUTOP in Pleryon's trial sites gives Pleryon richer endpoints and Ocuwell a pharma-trial use case.
Evidence from the records
- “First-in-human trial of candidate P002 (dry eye) authorized by Health Canada (ITA); no product on the market.”
- “OCUTOP used by clinicians on first patients”
- If it works
- Stronger clinical data package for licensing; new revenue line for Ocuwell in clinical research.
- First step
- Ask Ocuwell whether OCUTOP measurements fit P002's protocol endpoints and site setup.
